Just Cbd Soothing Unscented

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain. It is intended for use in patients experiencing acute pain conditions. Healthcare professionals should assess the appropriateness of this medication based on individual patient needs and the specific pain management requirements.

Dosage and Administration

For adults over 21 years of age, a small amount of the product should be applied directly to the affected area. The application should be followed by a gentle massage in a circular motion, allowing the product to set for a few seconds. This process may be repeated as necessary, but should not exceed 3 to 4 applications per day. The product is intended for topical use only.

Contraindications

The product should not be used in large quantities, particularly over raw surfaces or blistered areas, due to the potential for adverse effects in these conditions. No other contraindications have been identified.

Warnings and Precautions

For external use only. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur:

• Redness at the application site.

• Worsening of the condition being treated.

• Development of irritation.

• Persistence of symptoms beyond 7 days, or if symptoms resolve and then recur within a few days.

• Signs of injury, including pain, swelling, or blistering at the site of application.

These precautions are essential to ensure the safe and effective use of the product. Regular monitoring of the patient's condition is recommended to identify any adverse reactions promptly.

Side Effects

For external use only. Patients should discontinue use and consult a healthcare professional if any of the following adverse reactions occur: redness at the application site, worsening of the condition, development of irritation, or if symptoms persist for more than 7 days. Additionally, if symptoms clear up and then recur within a few days, patients are advised to stop use. Signs of injury, such as pain, swelling, or blistering at the site of application, also warrant immediate cessation of use and medical consultation.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Just Cbd Soothing Unscented (lidocaine hcl). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

This product is intended solely for use by healthy adults aged 21 years and older. There is no established safety or efficacy for pediatric patients, including children and adolescents. Therefore, its use in individuals under 21 years of age is not recommended.

Geriatric Use

Elderly patients, defined as those aged 65 years and older, are not the intended population for this product, which is specifically formulated for healthy adults aged 21 years and older. Therefore, the safety and efficacy of this product in geriatric patients have not been established.

Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the lack of clinical data may necessitate careful monitoring and evaluation of potential risks versus benefits. Given the absence of dosage adjustments or specific recommendations for this demographic, it is advisable to avoid prescribing this product to individuals within the geriatric age group.

Pregnancy

Pregnant patients should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the text. Therefore, healthcare professionals should exercise caution and consider individual patient factors when prescribing to this population. Regular assessment of renal function may be warranted to ensure safe and effective use of the medication in patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant regarding the potential for overdose with this medication. In cases where an overdose is suspected, immediate medical attention should be sought.

Healthcare providers are advised to monitor patients closely for any signs or symptoms that may arise from an overdose. Common symptoms may include, but are not limited to, severe drowsiness, confusion, respiratory distress, or any other unusual clinical manifestations.

Management of an overdose should be tailored to the individual patient and may involve supportive care, symptomatic treatment, and, if applicable, the use of specific antidotes. It is crucial to consult local poison control guidelines and follow established protocols for overdose management.

In all instances of suspected overdose, healthcare professionals should report the event to the appropriate regulatory authorities and document the incident thoroughly in the patient's medical record.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and other hypersensitivity reactions. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Patients should be advised to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is important to inform patients to monitor for any signs of redness, irritation, or worsening of their condition after application. They should be instructed to report if symptoms persist for more than 7 days, or if symptoms clear up and then recur within a few days.

Healthcare providers should emphasize the importance of using the product only as directed and to avoid contact with the eyes. Patients should be cautioned against using the product in large quantities, especially over raw surfaces or blistered areas. Additionally, they should be made aware of the need to seek medical attention if they experience any signs of injury, such as pain, swelling, or blistering at the site of application.

Storage and Handling

The product is supplied in a tightly closed container to ensure stability and integrity. It should be stored in a dry place at controlled room temperature, specifically between 59ºF and 86ºF (15ºC to 30ºC). Proper storage conditions are essential to maintain the product's efficacy and safety.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Just Cbd Soothing Unscented, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)